z-logo
Premium
Accumulation of heptaprenyl diphosphate sensitizes B acillus subtilis to bacitracin: implications for the mechanism of resistance mediated by the BceAB transporter
Author(s) -
Kingston Anthony W.,
Zhao Heng,
Cook Gregory M.,
Helmann John D.
Publication year - 2014
Publication title -
molecular microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.857
H-Index - 247
eISSN - 1365-2958
pISSN - 0950-382X
DOI - 10.1111/mmi.12637
Subject(s) - biology , bacitracin , microbiology and biotechnology , biochemistry , transporter , lipid ii , antibiotics , enzyme , gene , biosynthesis
Summary Heptaprenyl diphosphate ( C 35 ‐ PP ) is an isoprenoid intermediate in the synthesis of both menaquinone and the sesquarterpenoids. We demonstrate that inactivation of ytpB , encoding a C 35 ‐ PP utilizing enzyme required for sesquarterpenoid synthesis, leads to an increased sensitivity to bacitracin, an antibiotic that binds undecaprenyl pyrophosphate ( C 55 ‐ PP ), a key intermediate in cell wall synthesis. Genetic studies indicate that bacitracin sensitivity is due to accumulation of C 35 ‐ PP , rather than the absence of sesquarterpenoids. Sensitivity is accentuated in a ytpB menA double mutant, lacking both known C 35 ‐ PP consuming enzymes, and in a ytpB strain overexpressing the HepST enzyme that synthesizes C 35 ‐ PP . Conversely, sensitivity in the ytpB background is suppressed by mutation of hepT or by supplementation with 1,4‐dihydroxy‐2‐naphthoate, a co‐substrate with C 35 ‐ PP for MenA . Bacitracin sensitivity results from impairment of the BceAB and BcrC resistance mechanisms by C 35 ‐ PP : in a bceAB bcrC double mutant disruption of ytpB no longer increases bacitracin sensitivity. These results suggest that C 35 ‐ PP inhibits both BcrC (a C 55 ‐ PP phosphatase) and BceAB (an ABC transporter that confers bacitracin resistance). These findings lead to a model in which BceAB protects against bacitracin by transfer of the target, C 55 ‐ PP , rather than the antibiotic across the membrane.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here